News
Revolution Medicines to Acquire EQRx in $1 Billion Deal
Revolution Medicines, a clinical-stage oncology company, is set to acquire EQRx in an all-stock deal worth $1 billion.
Endeavour Mining Q2 Results Report
Endeavour Mining is set to report its Q2 results, with estimated revenue of $583 million and a decline in earnings per share. The company's net profit is projec...
Ferrari Exceeds Earnings Expectations in Q2
Ferrari surpasses Q2 earnings expectations, raises full-year guidance due to strong demand for luxury cars. However, shares fall in premarket trading.
Bitcoin and Cryptocurrencies Fall as Risk Appetite Fades
Bitcoin and other cryptocurrencies are experiencing a decline due to a selloff in risk-sensitive assets. Analysts predict a further downtrend.
Mega Millions Jackpot Continues to Grow
The Mega Millions jackpot has grown to $1.55 billion after 31 consecutive drawings without a winner.
Expedia Stock Plunges Despite Exceeding Earnings Expectations
Expedia stock takes a 9% dip despite exceeding earnings expectations in Q2. Revenue reaches record-breaking $3.36 billion, but falls short of projections amidst...
Laptop Sales for Back-to-School Season
As back-to-school season approaches, discover the best laptop deals available and choose the perfect one for your needs. Don't miss out on these amazing discoun...
Energy Fuels Expects Decline in Uranium Prices and Sales
Energy Fuels projects a decrease in uranium prices and sales, along with progress in revival of mines and rare earth project.
CFRA Analyst Downgrades General Motors Stock
CFRA analyst Garrett Nelson downgrades General Motors stock to 'strong sell' due to increased risk of a UAW strike and challenges in the EV market.
Big Tech Earnings Impact U.S. Stocks but WPP Signals Trouble for Tech Sector
WPP's first-half results show stock drop and downward outlook, signaling potential trouble for U.S. tech sector.